Comprehensive genomic profiling (CGP) is advancing precision oncology research through simultaneous analysis of multiple biomarkers in a single next-generation sequencing (NGS) assay.
In this talk, the speaker will discuss the benefits of CGP and how this technique is utilized in their lab. He will share their evaluation of the Oncomine Comprehensive Assay Plus for detection of multi-gene biomarkers, including homologous recombination repair deficiency (HRD) and mutational signatures.
1. Learn about Homologous Recombination Repair Deficiency occurring in some cancers (HRD)
2. Understand the different genomic testing approaches to assess HRD